ISSN 0970-7700
 
2020, Vol: 26, Issue: 2
26 / 2Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

1. JREIM Covering Letter and Authors Declaration Form (Section 1-5) Ver. Jan 2021
2. TITLE page - Abstract - References etc-Sections -1 to 6 (NEW 2020-21)
3.JREIM Proforma for Authors CV and Declaration cum Consent Form-Ver-R -151022
4. JREIM Template for Submitting Manuscript in JREIM

Original Research
Online Published: 16 Jun 2015
 


CLINICAL STUDY ON DIFFERENT MODES OF VIRECHANA IN THE MANAGEMENT OF EKA KUSHTHA (PSORIASIS)

B. S. PRAVEEN, T. B. TRIPATHY.


Abstract
30 patients of Eka Kushtha (Psoriasis) were selected and randomly divided into two
groups viz. Virechana Karma and Nitya Rechana. In Virechana Karma group, Snehapana was done
with Murchhita Ghrita followed by Virechana performed with 50 gm of Manibhadra Vataka. In
Nitya Rechana group, Manibhadra Vataka was administered in the dosage of 20 gm with lukewarm
water daily in the morning, empty stomach for a period of one month. Patients were followed up
for two months. Virechana Karma has provided better relief in symptom of Matsyashakala,
Asvedanam, Rukshata, Kandu and Koebner phenomenon. On the other hand Nitya Rechana showed
comparatively better improvement in Mandala and Candle grease sign. In Virechana Karma group
66.7% patients showed marked improvement, 20% patients had moderate improvement and 13.3%
patients had mild improvement. Whereas in Nitya Rechana group 20% showed marked improvement,
53.3% moderate improvement and 26.7% patients had mild improvement. Virechana Karma has
shown better improvement in the signs and symptoms of the Eka Kushtha (Psoriasis) as compared
to Nitya Rechana.

Key words: Eka kushtha, Psoriasis, Virechana karma, Nitya rechana, Manibhadra vataka, Ayurveda, Panchakarma, Hearbal drugs, Medicinal plants.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by B. S. PRAVEEN
Articles by T. B. TRIPATHY
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

B. S. PRAVEEN, T. B. TRIPATHY. CLINICAL STUDY ON DIFFERENT MODES OF VIRECHANA IN THE MANAGEMENT OF EKA KUSHTHA (PSORIASIS). J Res Educ Indian Med . 2011; 17(1-2): 57-63.

Web Style

B. S. PRAVEEN, T. B. TRIPATHY. CLINICAL STUDY ON DIFFERENT MODES OF VIRECHANA IN THE MANAGEMENT OF EKA KUSHTHA (PSORIASIS). https://www.jreim-ayushjournal.com/?mno=191773 [Access: September 13, 2024].

AMA (American Medical Association) Style

B. S. PRAVEEN, T. B. TRIPATHY. CLINICAL STUDY ON DIFFERENT MODES OF VIRECHANA IN THE MANAGEMENT OF EKA KUSHTHA (PSORIASIS). J Res Educ Indian Med . 2011; 17(1-2): 57-63.


Vancouver/ICMJE Style

B. S. PRAVEEN, T. B. TRIPATHY. CLINICAL STUDY ON DIFFERENT MODES OF VIRECHANA IN THE MANAGEMENT OF EKA KUSHTHA (PSORIASIS). J Res Educ Indian Med . (2011), [cited September 13, 2024]; 17(1-2): 57-63.


Harvard Style

B. S. PRAVEEN, T. B. TRIPATHY (2011) CLINICAL STUDY ON DIFFERENT MODES OF VIRECHANA IN THE MANAGEMENT OF EKA KUSHTHA (PSORIASIS). J Res Educ Indian Med , 17 (1-2), 57-63.


Turabian Style

B. S. PRAVEEN, T. B. TRIPATHY. 2011. CLINICAL STUDY ON DIFFERENT MODES OF VIRECHANA IN THE MANAGEMENT OF EKA KUSHTHA (PSORIASIS). Journal of Research and Education in Indian Medicine, 17 (1-2), 57-63.


Chicago Style

B. S. PRAVEEN, T. B. TRIPATHY. "CLINICAL STUDY ON DIFFERENT MODES OF VIRECHANA IN THE MANAGEMENT OF EKA KUSHTHA (PSORIASIS)." Journal of Research and Education in Indian Medicine 17 (2011), 57-63.


MLA (The Modern Language Association) Style

B. S. PRAVEEN, T. B. TRIPATHY. "CLINICAL STUDY ON DIFFERENT MODES OF VIRECHANA IN THE MANAGEMENT OF EKA KUSHTHA (PSORIASIS)." Journal of Research and Education in Indian Medicine 17.1-2 (2011), 57-63. Print.


APA (American Psychological Association) Style

B. S. PRAVEEN, T. B. TRIPATHY (2011) CLINICAL STUDY ON DIFFERENT MODES OF VIRECHANA IN THE MANAGEMENT OF EKA KUSHTHA (PSORIASIS). Journal of Research and Education in Indian Medicine, 17 (1-2), 57-63.


Author LoginReviewer LoginAbout PublisherEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPrivacy PolicyAdvertising PolicyLicense InformationCopyright Information

About Journal of Research and Education in Indian Medicine

The Journal of Research & Education in Indian Medicine (JREIM) is a quarterly peer-reviewed international journal. JREIM has been established and laun ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Websites
http://www.jreim-ayushjournal.com  and  
​http://www.ejmanager.com/my/jreim 
 

JREIM Head Office
B 29/19 Lanka, PO: BHU, Varanasi-221005 UP (India)   
e-mail:  jreim@ejmanager.com,
Tel: (+91) 9305180763

 

If you need to contact an editor, please use the contact details below:
e-mail: editor@jreim-ayushjournal.com, drlaxmi_ayush_journal@yahoo.com
Tel.: (+91) 9305180763 during office hours (10 AM to 5 PM, Monday to Friday)

Rana Gopal Singh, MD, DM
Editor-in- Chief, Integrative Medicine
 rgsingh@bhu.ac.in, profrgsingh@yahoo.com,  

Suresh Kumar, MD (Ayurveda), PhD
Editor-in- Chief, Ayurveda and Yoga
editor-in-chief@jreim-ayushjournal.com,  prof.suresh.india@gmail.com

Change of Address:
To change address or update your personal information, kindly visit your account (author/reviewer/editor) at http://www.ejmanager.com/my/jreim and update your profile.

If you have further queries, we would be happy to answer those. Please send
your queries to  manager@jreim-ayushjournal.com  or call us on +91 9305180763. 

------------------------

Medical advice:
JREIM (http://www.jreim-ayushjournal.com) does not give medical advice and will not be able to respond to inquiries about specific diseases, medical or surgical conditions, diagnosis, treatments or contact of another person.

Authors Contact:
To contact a author, use the information provided with the manuscript; JREIM will not be able to provide additional details.